GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Net Intangibles Purchase And Sale

CellaVision AB (OSTO:CEVI) Net Intangibles Purchase And Sale : kr0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

CellaVision AB's net Intangibles purchase and sale for the three months ended in Mar. 2025 was kr0.0 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.0 Mil.

CellaVision AB Net Intangibles Purchase And Sale Historical Data

The historical data trend for CellaVision AB's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Net Intangibles Purchase And Sale Chart

CellaVision AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Intangibles Purchase And Sale
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -31.80 -0.20 - -

CellaVision AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Intangibles Purchase And Sale Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CellaVision AB Net Intangibles Purchase And Sale Calculation

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellaVision AB Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Net Intangibles Purchase And Sale
Comparable Companies
OSTO:BICO OSTO:MCAP OSTO:PAX OSTO:OSSD OSTO:SEDANA OSTO:BACTI B OSTO:CRAD B OSTO:SEZI OSTO:INTEG B OSTO:BRAIN ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
0MR5:UK C26:Germany C26:Germany
Address
Mobilvagen 12, Lund, SWE, 22362
Website
https://www.cellavision.com
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines